Ullet index:KAKEN PHARMACEUTICAL CO.,LTD.:4521

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index KAKEN PHARMACEUTICAL CO.,LTD. Go to web site 4521 Medicals 東証プライム March 1, 2000 1961.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

KAKEN PHARMACEUTICAL CO.,LTD. mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 152,634
plusup
143,755
plusup
136,258
plusdown
137,747
plusup
136,257
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp 13,945
plusup
8,026
plusup
5,440
plusdown
9,549
plusdown
13,405
plus
Operating Cash Flow(OFC)Help 29,779
plusup
2,577
plusdown
9,253
plusdown
13,337
plusdown
14,379
plus
Free Cash Flow(FCF)Help 10,129
plusup
-3,277
plusdown
6,626
plusup
5,449
plusdown
12,735
plus
OFC - Net IncomeHelp 62
plusup
53
plusdown
54
plusdown
55
plusup
55
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp 40.47%
plusup
3.26%
plusdown
11.59%
plusdown
16.03%
plusdown
16.61%
plus
Current Assets / Amount of SalesHelp 78.26%
plusdown
109.80%
plusup
109.38%
plusdown
109.40%
plusdown
115.48%
plus
Free Cash Revenue RatioHelp 10.77%
plusup
-4.55%
plusdown
9.08%
plusup
7.17%
plusdown
16.98%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

KAKEN PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

K Pharma,Inc.
CHUGAI PHARMACEUTICAL CO., LTD.
ZERIA PHARMACEUTICAL CO.,LTD.
KYORIN Pharmaceutical Co., Ltd.
Toyama Chemical Co.,Ltd.
TAISHO PHARMACEUTICAL CO.,LTD.
Mitsubishi Tanabe Pharma Corporation
Sumitomo Pharma Co., Ltd.
Cyfuse Biomedical K.K.
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.